HCPLive

Fixing the Gout Knowledge Gap

$shareThis$


Since gout isn’t something that is taught in medical school there’s a gap in knowledge among primary care physicians about the treatment of gout, according to Theodore Fields, MD, director, Rheumatology Faculty Practice Plan at the Hospital for Special Surgery and a professor of clinical medicine at Weill Cornell Medical College.
 
“… there’s 8.3 million patients with gout out there and there’s not nearly enough rheumatologists to take care of them,” Fields says. “So most of the care of gout is going to be done by primary care.”

However even though there are key features of gout, there are “certain situations where you really can’t be sure,” he says.

Most Popular

Recommended Reading

Tenofovir alafenamide, which results in 90% lower circulating plasma tenofovir than standard tenofovir disoproxil fumarate, is associated with similar virologic response rates as the standard regimen, but with an improved safety profile.
Combination treatment with daclatasvir and asunaprevir plus interferon/ribavirin had high success rates in a 24-week clinical trial for treatment of hepatitis C in patients coninfected with HIV.
An interferon/ribavirin-free pill that combines two drugs to treat patients with certain genotypes of hepatitis C who are also infected with HIV was found to be highly effective in a 12-week trial, clearing the hepatitis C virus from almost all the patients involved.
Novel second-generation HIV-1 maturation inhibitor shows favorable antiviral activity and safety profile in HIV-1, subtype B-infected subjects
$vacMongoViewPlus$ $vAR$